Super Copper Corp. Reports Phase 1 Exploration Results at Cordillera Cobre Project
Super Copper Corp. announced the results of its Phase 1 field exploration program at the Cordillera Cobre copper project in Chile's Atacama region.
Stocks · News reference
Super Copper Corp. Provides Corporate Update on Exploration and Technology Milestones
Super Copper Corp. announced progress on its Cordillera Cobre and Castilla copper projects in Chile and reported that its CUPRIX copper recovery technology has reached bench-scale demonstration.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cuprina Holdings shares are trading lower. The company announced the acquisition of East Coast Podiatry and Orchard Clinic for ~$3.1 million.
Cuprina Holdings To Acquire East Coast Podiatry And Orchard Clinic For ~$3.1M
Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering
Cuprina Holdings (Nasdaq: CUPR), a biomedical company, announced the successful closing of its underwriter's over-allotment option, selling an additional 648,373 Class A ordinary shares at $1.15 per share for approximately $745,629 in gross proceeds. Combined with the initial public offering, the company raised total aggregate gross proceeds of approximately $5.72 million, which will be used for business expansion, R&D activities, market growth, and general corporate purposes.
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
Cuprina Holdings (Nasdaq: CUPR), a biomedical company focused on chronic wounds, infertility, medical waste recycling, and cosmeceuticals, closed its public offering of 4.32 million Class A Ordinary Shares at $1.15 per share, raising approximately $4.97 million in gross proceeds. The company plans to use net proceeds for R&D expansion, new market entry, brand building, and infrastructure investment. The offering follows FDA 510(k) clearance for MEDIFLY Maggots™ in June.
Crude Oil Down Over 3%; US Business Inventories Surge In July
U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.